Drug news
FDA recommends Trulign Toric (Bausch & Lomb) for Cataract surgery
The FDA's Ophthalmic Devices Panel voted 10-1 to recommend the approval of Bausch & Lomb Opthalmic's Trulign Toric intraocular lens to repair vision after Cataract surgery. The Trulign Toric intraocular lens is a multi-piece implant inserted into the capsular bag of the eye to correct problems stemming from cataract removal, restoring vision without spectacles.
The filing is based on a clinical study that included 229 patients, 227 of whom received a lens implant in one eye. The results showed that the Truligh Toric improved visual acuity with low rates of adverse events.